Citadel Advisors
APGE icon

Citadel Advisors’s Apogee Therapeutics APGE Stock Holding History

Citadel Advisors’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
33,700
+19,500
+137% +$1.42M ﹤0.01% 5386
2025
Q4 		$1.07M Sell
14,200
-6,300
-31% -$397K ﹤0.01% 7240
2025
Q3 		$814K Buy
20,500
+8,900
+77% +$340K ﹤0.01% 7990
2025
Q2 		$504K Buy
11,600
+3,800
+49% +$145K ﹤0.01% 8610
2025
Q1 		$291K Buy
7,800
+4,700
+152% +$182K ﹤0.01% 9668
2024
Q4 		$140K Sell
3,100
-5,200
-63% -$265K ﹤0.01% 10990
2024
Q3 		$488K Buy
8,300
+6,100
+277% +$292K ﹤0.01% 8309
2024
Q2 		$86.6K Buy
2,200
+2,000
+1,000% +$97.1K ﹤0.01% 11115
2024
Q1 		$13.3K Buy
+200
New +$8.73K ﹤0.01% 13308

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return